Advantage Solutions Inc. (ADV)

Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	3,527	3,566	3,900	3,646	3,602	3,156
Revenue Growth (YoY)	-8.08%	-8.56%	6.96%	1.22%	14.15%	-16.63%
Cost of Revenue	3,030	3,059	3,415	3,173	2,964	2,551
Gross Profit	496.74	507.27	485.08	472.85	638.18	604.19
Selling, General & Admin	181.02	205.24	179.74	143.87	129.65	199.6
Operating Expenses	386.19	409.79	388.6	359.91	369.69	438.2
Operating Income	110.56	97.48	96.48	112.94	268.49	165.99
Interest Expense	-159.83	-161.23	-182.1	-148.19	-144.66	-222.77
Interest & Investment Income	7.36	7.36	12.91	43.8	8.3	-
Other Non Operating Income (Expenses)	0.86	0.58	0.29	21.24	-0.96	-13.36
EBT Excluding Unusual Items	-38.79	-55.8	-72.42	29.78	131.17	-70.14
Merger & Restructuring Charges	-117.68	-117.68	-59.34	-24.92	-32.68	-90.59
Impairment of Goodwill	-	-	-	-1,368	-	-
Gain (Loss) on Sale of Assets	-	-	58.89	-2.86	-	-
Asset Writedown	-275.17	-275.17	-43.5	-205.02	-	-
Other Unusual Items	7.46	7.46	-2.49	-6.57	-7.33	-27.37
Pretax Income	-424.18	-441.19	-118.86	-1,577	91.17	-180.4
Income Tax Expense	-39.78	-62.79	-37.65	-158.44	33.62	-5.33
Earnings From Continuing Operations	-384.4	-378.4	-81.21	-1,419	57.55	-175.07
Earnings From Discontinued Operations	8.81	53.63	18.48	37.59	-	-
Net Income to Company	-375.59	-324.77	-62.73	-1,381	57.55	-175.07
Minority Interest in Earnings	-2.19	-2.19	-0.59	0.55	-3.06	-0.74
Net Income	-377.79	-326.96	-63.32	-1,381	54.49	-175.81
Net Income to Common	-377.79	-326.96	-63.32	-1,381	54.49	-175.81
Shares Outstanding (Basic)	322	322	324	319	318	223
Shares Outstanding (Diluted)	322	322	324	319	321	223
Shares Change (YoY)	-0.67%	-0.67%	1.57%	-0.72%	43.80%	9.56%
EPS (Basic)	-1.17	-1.02	-0.20	-4.33	0.17	-0.79
EPS (Diluted)	-1.17	-1.02	-0.20	-4.33	0.17	-0.79
Free Cash Flow	55.32	85.26	207.8	92.35	94.82	314.78
Free Cash Flow Per Share	0.17	0.27	0.64	0.29	0.29	1.41
Gross Margin	14.09%	14.22%	12.44%	12.97%	17.72%	19.15%
Operating Margin	3.14%	2.73%	2.47%	3.10%	7.45%	5.26%
Profit Margin	-10.71%	-9.17%	-1.62%	-37.86%	1.51%	-5.57%
Free Cash Flow Margin	1.57%	2.39%	5.33%	2.53%	2.63%	9.98%
EBITDA	315.72	302.04	305.34	328.98	508.53	404.59
EBITDA Margin	8.95%	8.47%	7.83%	9.02%	14.12%	12.82%
D&A For EBITDA	205.17	204.55	208.86	216.05	240.04	238.6
EBIT	110.56	97.48	96.48	112.94	268.49	165.99
EBIT Margin	3.14%	2.73%	2.47%	3.10%	7.45%	5.26%
Effective Tax Rate	-	-	-	-	36.87%	-

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q